Daniel Pine, MD

Dr. Daniel Pine is a chief of the Emotion and Development Branch in the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in 2000 after 10 years of training, teaching, and research at Columbia University. Since graduating from medical school at the University of Chicago, he has been engaged in research on pediatric mental disorders and has published more than 700 peer-reviewed papers. Currently, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function.

Dr. Pine served as the chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration, chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force, and president of the Society of Biological Psychiatry. He is a member of the National Academy of Medicine and a Distinguished Investigator (indicating he is among the 1–2% most impactful National Institute of Health intramural scientists), among many other awards.

• Food and Drug Administration, Chair of the Psychopharmacologic Drug Advisory Committee
• American Psychiatric Association, Blanche Ittelson Award
• American College of Neuropsychopharmacology, Joel Elkes Award
• NARSAD, Independent Investigator Award
• DSM-V Task Force, Chair of the Developmental Working Group

• University of Chicago, MD in Medicine, 1990
• Grinnell College, BA in Anthropology, 1985